IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q1 2020 Holdings

Filed 2020-05-11 | 5 holdings | $367.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines, Inc.(RVMD)COM76155X100$197.7K9,024,03153.8%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$71.2K5,962,20219.4%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$58.5K6,391,17615.9%
Neon Therapeutics, Inc.COM64050Y100$25.7K9,741,6367.0%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$14.5K3,048,7803.9%